The North America Biochips Market would witness market growth of 10.6% CAGR during the forecast period (2019-2025).
Applications of biochips in biochemistry, pharmacogenomics, microbiology, proteology, clinical pathology and analysis of DNAs are widely available. In terms of particular applications, biochips can be used to screen analytes for traces of biological warfare, drug discovery, and drug development, for the molecular diagnosis of disease and other diseases, for personalized medicine and to identify a wide range of biomolecules in general. Biochips also found more use in the applications of skin-on-a-chip.
North America represented a major share of the global market and is anticipated to continue its dominance in the forecast period. This is directly related to a rise in cancer incidence, development of the geriatric population and the use of biochips because of their extensive use. Moreover, in the future, market players are expected to see a significant amount of key stakeholders and the accessibility of advanced healthcare infrastructure.
Based on Product, the market is segmented into DNA Chip, Protein Chip, Lab-on-Chip and Other Products. Based on Application, the market is segmented into Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fluidigm Corporation, Horiba Ltd., PerkinElmer, Inc., OriGene Technologies, Inc., Dynamic Biosensors GmbH, Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Randox Laboratories Limited, Thermo Fisher Scientific, Inc.
Market Segmentation:
ByProduct
By Application
By End User
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 